About bsbh

This author has not yet filled in any details.
So far bsbh has created 117 blog entries.

Michael Stein

Dr Michael Stein, Chairman and CEO Oxstem Ltd.   Dr Michael Stein is a successful healthcare entrepreneur with a background in medical science. In 2001, he co-founded the Map of Medicine Ltd (“the Map”) with University College London. The Map was nationally licensed across NHS England (2005-15) and is today primarily used [...]

Michael Stein 2017-10-27T07:37:04+00:00

Ian Campbell

Ian Campbell Director for Health and Life Sciences, Innovate UK Dr Ian Campbell is an experienced executive in the life sciences. Ian joined Innovate UK in October 2016 as Director for Health and Life Sciences. Prior to that, he most recently served as Chief Executive of Arquer Diagnostics, a company developing and commercialising immunoassay [...]

Ian Campbell 2017-08-23T07:57:52+00:00

Karen Aiach

Karen Aiach Founder, Chief Executive Officer, Lysogene   Founder and CEO of Lysogene, Ms. Aiach is also the mother of a child with MPS IIIA. She has a strong business background starting her career with Arthur Andersen specializing in audit and transaction services. Her entrepreneurial experience includes founding and running a financial business consultancy. [...]

Karen Aiach 2017-08-10T13:01:53+00:00

Steve Bates

Steve Bates CEO, BioIndustry Association (BIA) Since his appointment as Chief Executive Officer of the BioIndustry Association in 2012, Steve Bates has led major BIA campaigns for, amongst other things, improved access to finance, the refilling of the Biomedical Catalyst, anti-microbial resistance and the opportunity the sector presents to generalist long term [...]

Steve Bates 2017-11-02T08:31:17+00:00

Adrien Lemoine

Adrien Lemoine VP Business Development & Operations, Orchard Therapeutics Adrien brings to Orchard Therapeutics more than 15 years of experience growing pharma and biotech businesses via in- and out-licensing, M&A and portfolio development. Prior to joining Orchard, Adrien was Executive Director, Corporate Strategy and Development at AstraZeneca where he was leading M&A [...]

Adrien Lemoine 2017-10-27T07:34:51+00:00

Deborah Morrison

Deborah Morrison Senior Scientific Adviser, NICE Deborah leads on several strategic initiatives within the scientific advice team. She holds an Honours Degree in Pharmacy and a Clinical Diploma in Clinical Pharmacy. Previously, Deborah was responsible for developing a series of combined clinical and commissioning roles within Cambridgeshire Primary Care Trust and NHS Cambridgeshire [...]

Deborah Morrison 2017-08-09T09:14:59+00:00

Barbara Freischem

Barbara Freischem Executive Director, European Biopharmaceutical Enterprises (EBE) Barbara Freischem is Executive Director of the European Biopharmaceutical Enterprises (EBE), since July 2015. EBE is a specialised group within the European Federation of Pharmaceutical Industries and Associations (EFPIA), representing biopharmaceutical companies of all sizes. Barbara has worked at national, European and international level. Starting [...]

Barbara Freischem 2017-08-09T09:15:00+00:00

Magda Papadaki

Magda Papadaki Head of Product and Process Innovation, Association of the British Pharmaceutical Industry (ABPI) Dr Magda Papadaki, is Head of Product and Process Innovation for ABPI. She is responsible for UK’s pharma strategy in innovative products and ATMPs, new Synthetic Biology R&D tools and novel platforms for their production and regulatory/clinical [...]

Magda Papadaki 2017-10-27T07:30:22+00:00

Qasim Rafiq

Qasim Rafiq Senior Lecturer (Assistant Professor) Bioprocessing of Regenerative, Cellular and Gene Therapies, UCL I am currently a Lecturer (Assistant Professor) in Bioprocess Engineering at Aston University with a specific research focus on the manufacture, translation and commercialisation of cell, gene and tissue-based therapies. In my first 12 months as a Lecturer, I [...]

Qasim Rafiq 2017-08-09T09:15:00+00:00

James McBlane

James McBlane CAT Member, Preclinical Assessor, UK Medicines and Healthcare Products Regulatory Agency (MHRA) After degrees in pharmacology at Dundee and Aston universities, Dr McBlane worked for Wellcome and then at the UK Medicines Control Agency before moving to the Japanese biopharmaceutical company, Chugai, for 10 years, latterly specialising in preclinical development.  He [...]

James McBlane 2017-08-09T09:15:00+00:00